Publications
72
Citations
399
Est. group size
~21
Recurring co-author estimate
Active years
8
Publishing since 2019
Typically publishes in teams of ~11 · 14% small-team papers (≤3 authors) · across 8 venues
- Optimal Treatment Sequence for CDK4/6 Inhibitors and Radiation Combination Therapy in Triple Negative and Estrogen Receptor Positive Breast Cancer
International Journal of Radiation Oncology*Biology*Physics · 2025
- Novel Radiosensitizer Screen Identifies an Effective Strategy to Treat p53 Wild-Type Breast Cancer Models in a Hormone Independent Manner
International Journal of Radiation Oncology*Biology*Physics · 2024
- Optimal Treatment Sequence for CDK4/6 Inhibitors and Radiation Combination Therapy in Estrogen Receptor-Positive Breast Cancer
International Journal of Radiation Oncology*Biology*Physics · 2024
- Targeting DNA Damage, Apoptosis, and the Cell Cycle for the Radiosensitization of Aggressive Forms of Breast Cancer
Deep Blue (University of Michigan) · 2022
- Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer
Frontiers in Genetics · 2021
- Modulating the Radiation Response for Improved Outcomes in Breast Cancer
JCO Precision Oncology · 2021
- Abstract 737: Estrogen receptor inhibition with tamoxifen mediates radiosensitization of ER+ breast cancer models
Cancer Research · 2021
- Abstract PS5-25: Association of OPG rs2073618 and aromatase inhibitor induced musculoskeletal symptoms
Cancer Research · 2021
- Inhibition of Estrogen Receptor Signaling as a Strategy for Radiosensitization of ER+ Breast Cancers
International Journal of Radiation Oncology*Biology*Physics · 2021
- Role of Vitamins A and D in BCR-ABL Arf−/− Acute Lymphoblastic Leukemia
Scientific Reports · 2020
- A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive Recurrences
International Journal of Radiation Oncology*Biology*Physics · 2020
- Impact of CYP3A5 Phenotype on Tacrolimus Concentrations After Sublingual and Oral Administration in Lung Transplant
Pharmacogenomics · 2019
- Abstract 3924: PARP inhibition as a radiosensitizing strategy to improve locoregional control in inflammatory breast cancer
Cancer Research · 2019
- Abstract 3924: PARP inhibition as a radiosensitizing strategy to improve locoregional control in inflammatory breast cancer
Experimental and Molecular Therapeutics · 2019
- Cancer Research×18
- International Journal of Radiation Oncology*Biology*Physics×8
- npj Breast Cancer×3
- Clinical Cancer Research×2
- Pharmacogenomics×2
- Benjamin C. Chandler
Medicine · University of Michigan
- Anna R. Michmerhuizen
Medicine · University of Michigan
- Nicole Hirsh
Medicine · University of Michigan
- Meilan Liu
Medicine · University of Michigan
- Lynn M. Lerner
Biochemistry, Genetics and Molecular Biology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile